Vertaile menetelmiä
Tarkastele valitsemiasi menetelmiä rinnakkain; eroavat rivit korostetaan.
| Bayesian ChIP-seq peak calling× | Epigenomilaajuinen Assosiaatiotutkimus (EWAS)× | |
|---|---|---|
| Tieteenala | Bioinformatiikka | Bioinformatiikka |
| Menetelmäperhe | Process / pipeline | Process / pipeline |
| Syntyvuosi≠ | 2008–2009 | 2008–2011 (term and framework established c. 2011) |
| Kehittäjä≠ | Spyrou et al. (BayesPeak, 2009); broader Bayesian ChIP-seq framework developed across multiple groups ~2008–2012 | Rakyan, Down, Balding & Beck (conceptual framework); Illumina arrays enabled large-scale application |
| Tyyppi≠ | Probabilistic signal detection pipeline | Population-scale epigenomic association study |
| Alkuperäislähde≠ | Zhang, Y., Liu, T., Meyer, C. A., Eeckhoute, J., Johnson, D. S., Bernstein, B. E., Nusbaum, C., Myers, R. M., Brown, M., Li, W., & Liu, X. S. (2008). Model-based analysis of ChIP-Seq (MACS). Genome Biology, 9(9), R137. DOI ↗ | Rakyan, V. K., Down, T. A., Balding, D. J., & Beck, S. (2011). Epigenome-wide association studies for common human diseases. Nature Reviews Genetics, 12(8), 529–541. DOI ↗ |
| Rinnakkaisnimet | Bayesian ChIP-seq analysis, probabilistic peak detection, Bayesian peak caller, ChIP-seq Bayesian enrichment calling | EWAS, methylome-wide association study, epigenetic association study, DNA methylation association study |
| Liittyvät≠ | 6 | 5 |
| Tiivistelmä≠ | Bayesian ChIP-seq peak calling applies probabilistic models — typically Poisson, negative binomial, or hidden Markov models with Bayesian inference — to detect genomic regions enriched for a protein of interest in chromatin immunoprecipitation followed by sequencing experiments. By explicitly modelling read-count noise and incorporating prior distributions, Bayesian callers yield posterior probabilities of enrichment rather than simple p-values, providing a principled framework for uncertainty quantification across the genome. | An epigenome-wide association study (EWAS) is a hypothesis-free, genome-scale method that systematically tests whether epigenetic marks — predominantly CpG-site DNA methylation — differ between individuals with and without a trait, disease, or exposure. By scanning hundreds of thousands of genomic positions simultaneously, EWAS identifies loci where the epigenome is reproducibly associated with a phenotype, offering a layer of biological regulation that classical GWAS does not capture. |
| ScholarGateAineisto ↗ |
|
|